Gilead’s Kite Pharma has agreed to purchase Interius BioTherapeutics for $350 million. This deal will help Kite expand its work […]
Anne White, the Executive Vice President and President of Lilly Neuroscience at Eli Lilly and Company, will retire at the
Eli Lilly is looking for a new leader for its neuroscience division after announcing that Anne White, the current head,
In this project, ANGLE’s research team will use the Parsortix system to collect cancer cells from the blood of cancer
Johnson & Johnson (J&J) has made a major move to strengthen its US manufacturing operations by signing a $2 billion,
The US Centers for Disease Control and Prevention (CDC) reports that about one in six Americans struggles with substance use
AstraZeneca’s journey in lung cancer treatment began in 2003 with a drug called Iressa, which targeted a specific gene mutation
The International Council for Harmonisation (ICH) has opened a public consultation on its draft guidelines for managing drug impurities caused
Teva Pharmaceuticals has received FDA approval for AJOVY (fremanezumab-vfrm) as a preventive treatment for episodic migraines in children and adolescents
Eli Lilly has shared promising results from its large-scale study comparing Mounjaro (tirzepatide) with Trulicity (dulaglutide) in adults with type